Merck Announces Second-Quarter 2013 Financial Results

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2013.
$ in millions, except EPS amounts  

Second Quarter 2013

Second Quarter 2012
Sales   $11,010   $12,311
GAAP EPS   0.30   0.58

Non-GAAP EPS that excludes items listed below 1
  0.84   1.05

GAAP Net Income 2
  906   1,793
Non-GAAP Net Income that excludes items listed below 1,2   2,530   3,227

Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.84 exclude acquisition-related costs, restructuring costs and certain other items.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts